Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controlsOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study characterized the gut microbiome of women with locally advanced cervical cancer using 16S rDNA sequencing of fecal samples. Researchers measured alpha diversity (within-sample diversity, via the Shannon diversity index) and beta diversity (between-sample diversity, via unweighted Unifrac distances and principal coordinate analysis). They then compared relative abundance of microbial taxa between groups using LEfSe (Linear Discriminant Analysis Effect Size), adjusting for age and race.
Who was studied?
The study included 42 women with locally advanced cervical cancer and 46 healthy female controls. Fecal samples from these two groups were profiled and compared directly. The abstract does not provide further demographic detail beyond the age- and race-adjusted analysis used in the statistical comparisons.
What were the most important findings?
Alpha diversity was significantly higher in cervical cancer patients than in controls, though this difference was driven mainly by older women (over 50 years). Notably, alpha diversity correlated positively with age in cancer patients but inversely with age in controls, suggesting opposite age-related diversity trends between the two groups. Beta diversity also differed significantly between cervical cancer patients and controls, and age- and race-adjusted LEfSe analysis identified multiple taxa that differed between groups, including Prevotella and Porphyromonas.
What are the greatest implications of this study?
The findings suggest that cervical cancer is associated with detectable, age-dependent shifts in gut microbial community structure and composition. The identification of specific differentially abundant genera, such as Prevotella and Porphyromonas, points to candidate taxa that could be further investigated for mechanistic links to cervical cancer. These results support continued investigation of the gut microbiome as a potential factor in cervical cancer biology, though the abstract does not describe causal mechanisms or clinical applications.